Developing precision medicines to treat and cure cardiovascular disease.
| Title |
|---|
| VP, Head of Clinical Operations Full Time · $1-$2 · 15+ YOE Princeton, New Jersey, United States · Onsite |
| Director, Corporate Strategy Full Time · $197K-$257K · 7+ YOE Chicago, Illinois, United States · Onsite |
| Senior Accountant, Accounting Full Time · $123K-$160K · 8+ YOE South San Francisco, California, United States · Onsite |
| Executive Director, Development Business Operations Full Time · $260K-$338K · 12+ YOE Princeton, New Jersey, United States · Onsite |
| Executive Director, Head of Global Site Management Full Time · $274K-$357K · 12+ YOE Princeton, New Jersey, United States · Onsite |
| Sr. Manager, Clinical Trial Lead Full Time · $166K-$216K · 8+ YOE Princeton or South San Francisco · Onsite |
| Associate Director, Biostatistics Full Time · $174K-$244K · 7+ YOE South San Francisco or Princeton · Onsite |
| Associate Director, Drug Substance Development Full Time · $202K-$263K · 10+ YOE Princeton, New Jersey, United States · Hybrid |
| Activities | Cardiovascular drug developmentClinical stage biotechnologyTherapeutic asset licensingPrecision medicine R&DBiopharmaceutical manufacturing |
| Headquarters | US |
| Industries | BiotechnologyPharmaceuticals |
| Name | Kardigan |
| Employees | 56 |
| Type | Private |
| Subsidiaries | Prolaio |
| Tagline | Developing precision medicines to treat and cure cardiovascular disease. |
| Founded | 2,023 |
| Website | kardigan.bio |
| Latest Funding Round | Series B |
| Latest Funding Year | 2,025 |
| Latest Funding Amount | 254,000,000 |
| Latest Investors | Fidelity Management & Research CompanyT. Rowe Price Investment Management |